Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trialKohei Shitara, Min‐Hee Ryu, Lorenzo Fornaro et al.|The Lancet|2018Cited by 1.3k
Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane TreatmentE. Donnall Thomas, Henri Roché, Henry Gómez et al.|Journal of Clinical Oncology|2007Cited by 483
Efficacy and Safety of Ixabepilone (BMS-247550) in a Phase II Study of Patients With Advanced Breast Cancer Resistant to an Anthracycline, a Taxane, and CapecitabineEdith A. Perez, Gabriel N. Hortobágyi, Xavier Pivot et al.|Journal of Clinical Oncology|2007Cited by 392